Concurrent use of oral contraceptives with antidepressants for premenstrual syndromes [8]

Journal of Clinical Psychopharmacology

Volumn 21, Issue 5, 2001, Pages 540-542

  Freeman, Ellen W ^a,b   Rickels, Karl ^a,b   Sondheimer, Steven J ^a,b   Polansky, Marcia ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; DESIPRAMINE; ORAL CONTRACEPTIVE AGENT; PLACEBO; SERTRALINE;

ADULT; APPETITE DISORDER; BEHAVIOR; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DYSPHORIA; FEMALE; HUMAN; LETTER; MAJOR CLINICAL STUDY; MOOD; PAIN; PREMENSTRUAL SYNDROME; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYMPTOM; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTIDEPRESSIVE AGENTS; CONTRACEPTIVES, ORAL; DESIPRAMINE; DOUBLE-BLIND METHOD; DRUG INTERACTIONS; FEMALE; HUMANS; MIDDLE AGED; POLYPHARMACY; PREMENSTRUAL SYNDROME; SERTRALINE; SEVERITY OF ILLNESS INDEX;

EID: 0034796045     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004714-200110000-00018     Document Type: Letter

References (19)

1. Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome
2. Premenstrual changes and changes in gonadal hormones
3. Daily plasma estradiol and progesterone levels over the menstrual cycle and their relation to premenstrual symptoms
4. Relationship between symptom severity and steroid variation in women with premenstrual syndrome: Study on serum pregnenolone, pregnenolone sulfate, 5ä-pregnane-3,20-dione and 3ä-hydroxy-5ä-pregnan-20-one
5. Psychosocial implications of oral contraceptive use
6. Hormones as treatments: Hormonal interventions with psychopharmacological potential: An overview
7. A prospective treatment study of premenstrual symptoms using a triphasic oral contraceptive
8. Oral contraceptives in premenstrual syndrome: A randomized comparison of triphasic and monophasic preparations
9. Possible antidepressant effect of oral contraceptives: Case report
10. Differential response to antidepressants in women with premenstrual syndrome/premenstrual dysphoric disorder: A randomized controlled trial
11. A double-blind trial of oral progesterone, alprazolam and placebo in treatment of severe premenstrual syndrome
12. A rating scale for depression
13. Efficacy and safety of fluoxetine in patients taking oral contraceptives
14. Prevalence of menstrual cycle symptom cyclicity and premenstrual dysphoric disorder in a random sample of women using and not using oral contraceptives
15. Relationship between premenstrual symptoms and oral contraceptive use: A controlled study
16. The relationship between retrospective premenstrual symptom reporting and present oral contraceptive use